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Abstract
Bacterial surface peptide display has gained popularity as a method of affinity reagent generation for a wide variety of
applications ranging from drug discovery to pathogen detection. In order to isolate the bacterial clones that express
peptides with high affinities to the target molecule, multiple rounds of manual magnetic activated cell sorting (MACS)
followed by multiple rounds of fluorescence activated cell sorting (FACS) are conventionally used. Although such manual
methods are effective, alternative means of library screening which improve the reproducibility, reduce the cost, reduce
cross contamination, and minimize exposure to hazardous target materials are highly desired for practical application.
Toward this end, we report the first semi-automated system demonstrating the potential for screening bacterially displayed
peptides using disposable microfluidic cartridges. The Micro-Magnetic Separation platform (MMS) is capable of screening a
bacterial library containing 3610
10 members in 15 minutes and requires minimal operator training. Using this system, we
report the isolation of twenty-four distinct peptide ligands that bind to the protective antigen (PA) of Bacilus anthracis in
three rounds of selection. A consensus motif WXCFTC was found using the MMS and was also found in one of the PA
binders isolated by the conventional MACS/FACS approach. We compared MMS and MACS rare cell recovery over cell
populations ranging from 0.1% to 0.0000001% and found that both magnetic sorting methods could recover cells down to
0.0000001% initial cell population, with the MMS having overall lower standard deviation of cell recovery. We believe the
MMS system offers a compelling approach towards highly efficient, semi-automated screening of molecular libraries that is
at least equal to manual magnetic sorting methods and produced, for the first time, 15-mer peptide binders to PA protein
that exhibit better affinity and specificity than peptides isolated using conventional MACS/FACS.
Citation: Kogot JM, Zhang Y, Moore SJ, Pagano P, Stratis-Cullum DN, et al. (2011) Screening of Peptide Libraries against Protective Antigen of Bacillus anthracis in
a Disposable Microfluidic Cartridge. PLoS ONE 6(11): e26925. doi:10.1371/journal.pone.0026925
Editor: Anna Mitraki, University of Crete, Greece
Received September 1, 2011; Accepted October 5, 2011; Published November 28, 2011
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for
any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Funding: This work was supported in part by the U.S. Army, through the Institute of Collaborative Biology at University of California Santa Barbara, under grant
DAAD19-03-D-0004, in part by an appointment to the Internship/Research Participation Program for the U.S. Army Research Laboratory administered by the Oak
Ridge Institute for Science and Education through an agreement between the U.S. Department of Energy and the U.S. Army Research Laboratory, and in partb y
the Defense Threat Reduction Agency-Joint Science and Technology Office for Chemical and Biological Defense (Grant no. BRCALL08-Per3-P-2-0028). The funders
had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: Zhang Y, Pagano P, Chang-Yen D, Turewicz M and de Fusco A are employed by Cynvenio Biosystems, Inc. Moore S and Stagliano N are
employed by CytomX Therapeutics. The instrument reported herein is not currently marketed commercially by Cynvenio Biosystems, nor does CytomX
Therapeutics market the eCPX library. There are no patents, products in development or marketed products to declare. This does not alter the authors’ adherence
to all the PLoS ONE policies on sharing data and materials.
* E-mail: dimitra.n.stratis-cullum.civ@mail.mil
Introduction
Affinity reagents are molecular recognition elements (MREs)
that specifically bind to their targets with high affinity. Thus, their
effectiveness constitutes the first and the most important step in
pathogen detection and response. Hybridoma monoclonal anti-
body generation technology has been the most common method
for isolating affinity reagents for more than 30 years. However,
hybridoma technology requires significant time, cost, and
resources [1,2]. As a result, the demand for high performance
affinity reagents for novel molecular targets outpaces the current
technology. Currently, a number of synthetic alternatives to
hybridoma technology are under development including mRNA
and ribosome display [3], eukaryotic virus display [4,5], and
bacterial and yeast surface display [6,7] to more rapidly generate
affinity reagents that can be used for diagnostics, proteomics, and
therapeutic applications [8,9].
When considering the desire to automate the selection process
coupled with the overall time required to develop new recognition
binders against a target of interest, the bacterial display is uniquely
advantageous. The bacterial display technology offers an alternate
strategy for generating tailor-made affinity ligands in a short time
period (e.g., days to weeks), since one round of selection or
screening can be performed in one day with bacterial cells [6,10].
In this method, cellular machinery is used to generate billions of
diverse polypeptide molecules that can be screened with high
throughput methods to identify unique polypeptide sequences for
a desired target [10]. Briefly, the fifteen amino acid, random
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during arabinose induction on a circularly permutated derivative
of the outer membrane protein, OmpX, referred to as eCPX
[11,12]. The eCPX enables better peptide display off of the
membrane surface, and is a biterminal display scaffold, displaying
both the random peptide as a flexible linear sequence at the N-
terminus and an expression tag sequence at the C-terminus for
expression normalization [12]. Bacterial display libraries using
either the OmpX or eCPX have been used previously to isolate
polypeptide binding reagents to streptavidin [12], vascular
endothelial growth factor (VEGF) [13], adult neural stem cells
[14], protease activated pro-domains [15], and classification of
breast tumor subtypes [16].
To isolate the bacterial clones which express peptide sequences
with high affinity to the target, conventional approaches require
multiple rounds (often three sorting rounds) of magnetic separation
for pre-enrichment followed by fluorescence activated cell-sorting
(FACS). FACS sorting is limited to at most 10
8 cells in one session,
whereas magnetic sorting can accommodate 10
9 to 10
10 clones per
sort with more rapid results and greater recovery [17,18,19,
20,21,22]. Although this hybrid approach has proven to be
effective over manual magnetic sorting, it is labor-intensive, and
the sorting results are known to be operator-dependent [23].
Furthermore, the high capital and maintenance cost of FACS
instruments limit its accessibility. Another limitation of FACS for
both medical and DoD applications is the potential for generating
an aerosolized biohazard at the nozzle when dealing with
infectious pathogens; additional steps need to be taken to reduce
this hazard, such as adding an aerosol management unit, further
increasing cost.
To address the need for a rapid, safe, efficient, cost effective, and
reproducible affinity ligand selection, we have developed a semi-
automated magnetic bacterial cell sorting system, the micromag-
netic cell sorter (MMS), equipped with disposable microfluidic
cartridges (Figures 1, 2). As an alternative to glass MMS cartridges
[24] these low cost , highly reproducible and disposable polypro-
pylene cartridges are autoclavable and limit any aerosolization of
potential biohazards during library sorting, since all the fluid
management, mixing, and sorting is accomplished within the card.
The ability to perform semi-automated sorting in a disposable, self-
contained microfluidic cartridge with reproducible results is critical
fortheDoDsinceanynewdefensethreatscould be safelysortedina
native state ahead of any available recombinant form.
In order to evaluate the potential of a platform for bacterial
library sorting, there are several key capabilities that must be
considered. For example, high throughput screening is desired to
handle large libraries (several mL of .10
10 member libraries) in a
reasonable time frame (several minutes). Without rapid through-
put, practical application will be difficult. Typically with the
currently employed sorting technologies relying on a combination
of MACS and FACS sorting, the throughput is determined by the
MACS sample pre-enrichment prior to FACS sorting since
fluorescence cell sorting methods using ultra high-speed sorting
only approach 100,000 cells/sec [25] .
The recovery or fraction of binders collected relative to the total
number of binders in the naı ¨ve library is extremely critical to not
only affinity ligand development but also applications in medicine
for cell identification, such as cancer cell isolation and population
enrichment [26,27,28]. To assess recoverability, experiments were
conducted on the MMS system to determine the rare cell and
ultra-rare cell recovery (populations less than 0.001%) capability of
the instrument compared to manual MACS [25,26]. The
automated MMS platform presented herein is designed for greater
consistency and reliability compared to the manual MACS.
To demonstrate the sorting ability of the MMS system to isolate
peptide binders, protective antigen (PA) protein of Bacillus anthracis
was chosen for evaluation. The eCPX (CytomX Therapeutics; San
Francisco, CA) bacterial display library [11], expressing ,3610
10
discreet random 15 amino acid peptides, was screened for affinity
reagents capable of binding to PA. Of note, comparable results to
manual MACS and FACS screening were obtained and are
presented herein. In addition, excellent recovery performance
through MMS selection yields a consensus sequence among 24
unique binders and directly correlates to the best MACS/FACS
binder sequence. The affinity of several clones were characterized
using flow cytometry analysis to investigate the range of binding
affinity in products using both conventional and MMS isolation.
Results
The MMS exhibited better overall rare-cell recovery compared
to manual MACS when evaluating the reproducibility of the rare-
cell recovery in each method, as noted by the greater between-
sample variance in the manual MACS samples in four
independent trials, shown in Figure 3. The MMS had equivalent
rare-cell recovery within experimental error with specific percent-
age at 10
23 (95% to 65% recovery), 10
24 (85% to 75% recovery),
and 10
25 (40% to 38% recovery) of the initial rare-cell population
and nearly equivalent rare-cell recovery at 10
26 (15% to 15%),
10
27 (5% to 5%), and 10
28 (1% to 3%) (Fig. 3). The MMS had a
lower overall average RMSD compared to manual MACS, 7.47%
and 18.6% respectively. Both MMS and manual MACS
demonstrated the capability for ultra-rare cell recovery of at
initial rare-cell populations as low as 10
28 (Fig. 3). Statistical
analysis of the MMS and MACS recovery at each rare cell
population was performed using a Wilcoxon Matched-Pairs
Signed-Ranks Test since the outcome of both sorting methods
was dependent on the initial spiked-sample. The within population
results (for 10
23 to 10
28) for the MMS and MACS comparison
suggested no statistical difference between the methods. Only the
10
24 (p-value=0.125) had differences approaching the 90%
confidence limit with the small sample size tested (N=4). Analysis
of the entire sample (N=24) resulted in a p-value=0.3104, further
confirming there was no statistical difference between the
magnetic sorting methods.
For the evaluation of peptide binder selection by MMS and
manual MACS from the peptide display library, the FACS
analysis showed that after one round of MMS selection, the
frequency of cells capable of binding to PA reached 0.7%, the
second and third rounds further enriched the population to 56.1%
and 65.5% respectively, with MMS selection (Figure 4), which is
similar to the 56.4% seen for the MACS/FACS sort after two
rounds of manual MACS and three rounds of FACS (Figure 5).
Individual clones were picked at random from the positive
populations and sequenced (Genewiz, South Plainfield, NJ).
Sequences were analyzed and aligned using the Vector NTI
(Invitrogen, Carlsbad, CA) software suite (Figure 6). Sequencing of
24 clones obtained after three rounds of sorting yielded 15 clones
displaying a consensus motif WXCFTC. After repeating the
selection process, a total of 24 distinct peptide sequences showed
the WXCFTC consensus (Figure 6). This consensus was also
found in one of the PA binders isolated the conventional MACS/
FACS approach (Fig. 6).
Ten randomly selected MMS derived clones and fourteen
MACS clones expressing peptides with the consensus sequences all
show binding to 150 nM PA as measured by flow cytometry
(Table 1). The MMS_128 had the greatest PA binding at 89.8%
and only 0.2% for SAPE binding, which is greater than the best
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and 16.3% SAPE binding. A number of the single clones analyzed
for PA binding (Table 1) also show binding to Streptavidin (using
SAPE), especially clones MMS_188, MACS_545, MACS_572, and
MACS_575. Although not all of the MMS clones were tested, the
amount of non-specific binding is greater in the MACS samples,
with 10 of 14 clones having SAPE binding above 1.0% while only 1
of 10 MMS clones tested show SAPE binding greater than 1.0%.
In Figure 7, on-cell binding affinity analysis of 5 of the MMS
clones with the comparable MACS/FACS sequence (MACS_545)
was performed using dye-labeled PA (PA-dylight 488). The highest
affinity PA binder was MACS_133 at 16.5 nM PA-488, which had
twice the affinity of the best MACS/FACS binder
(MACS_545=35.8 nM). Two other MMS clones tested showed
higher binding affinity than the MACS/FACS sample, MMS_105
and MMS_111, which had affinities of 19.1 nM and 29.5 nM
Figure 1. MMS Platform. A) MMS disposable cartridge with front side showing sample luer interfaces and backside showing separation region, on-
cartridge valves and fluid path ways; B) automated MMS instrument with a volumetric control module for precise fluid injection speeds and volumes;
C) Stepper motors are implemented to actuate injectors with micro-switches for injector location sensing; D) Off-shelf syringes are used as injectors
for volumetric sample injection.
doi:10.1371/journal.pone.0026925.g001
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clones tested, KD=54.9 nM.
Discussion
A high throughput, semi-automated micromagnetic sorter
(MMS) platform for bacterial display library sorting was
introduced and described. Characterization of the MMS system’s
performance was achieved by screening against PA from Bacillus
anthracis. Semi-automated magnetic activated cell sorters are not
currently available for display library screening; therefore, results
obtained using the MMS platform were directly compared to
those obtained using conventional MACS/FACS sorting. In this
work, we demonstrated that the semi-automated MMS platform is
capable of effectively enriching affinity peptides against potential
biological warfare agents with high throughput. For a typical 1 mL
sample volume, MMS requires only 5 mins of user interaction,
while manual selection requires more than 20 mins.
Three key parameters are used to evaluate cell sorting. The first
parameter is throughput, which measures how many cells can be
sorted per second. The MMS platform achieves high throughput
screening since it is capable of screening a bacterial library
containing 3610
10 members in 15 mins. With regard to gross
throughput per hour, MMS is able to process 5610
12 cells/hr
(50 mL/hr at a cell concentration of 1610
11 cells/mL), which is
four orders of magnitude higher than that achieved using state-of-
art FACS instrumentation or a previously reported dielectro-
phoretic cell sorter [29]. The surface area of the trapping region
(Fig. 2) in the MMS disposable cartridge is a distinct advantage
over manual MACS, which typically uses a 1.5 ml tube and
benchtop magnetic for trapping. The trapping region in the MMS
card is approximately 11.3 cm
2 with magnetic trapping taking
place on the top and bottom of the card (22.6 cm
2 total area),
while the 1.5 ml tube has a trapping region of approximately
3.2 cm
2 on one side of the tube.
The remaining cell sorting evaluation parameters are purity and
recovery. Purity describes the fraction of collected cells which
actually bind target, and is evaluated using flow cytometry
analysis of PA binder populations in the positive sample and the
negative control sample as shown in Figures 4 and 5. The MMS
displays comparable results to MACS/FACS for purity, with
MMS having 65.1% PA binder population compared to 56.4% in
MACS/FACS after 3 rounds of sorting (Figs. 4, 5). Recovery (the
fraction of binders collected relative to the total number of
binders in the naı ¨ve library) is assessed using a direct comparison
of the MMS and MACS rare-cell and ultra-rare cell recovery
results (Figure 3). Both magnetic sorting methods achieve ultra-
rare cell recovery as shown by the sample population recovery
down to 10
28. The MMS had greater overall total rare-cell
recovery in the 0.1% and 0.01% (Fig. 3) samples compared to
manual MACS, which is likely attributed to the greater surface
area of the trapping region in the MMS card for accommodating
a greater number of magnetic beads and cells. The manual
MACS shows slightly better recovery at 10
28, which could be
due to sample loss during the transfer from sample mixing tube to
the syringe needed for MMS loading. For a more complete ultra-
rare cell recovery at 10
28, a second round of cell-recovery
following an overnight growth cycle would be beneficial for
improved overall sample recovery for both the manual MACS
and MMS.
Using the MMS, high affinity PA binders were isolated, which
showed twice the affinity of the best MACS/FACS binder (Fig. 7).
The isolated MMS clones also had lower overall binding to
SAPE, 100-fold less binding on average, than the MACS clones
(Table 1). This could be attributed to the use of the 1 mM biotin
solution during PA selection, which seemed to decrease the
streptavidin cross-reactivity in the MMS samples. Alternatively,
the use of alternating SAPE and a-biotin PE FACS (during
MACS/FACS analysis) selection did not seem to eliminate the
SAPE cross-reactivity. Streptavidin clone enrichment in MACS
and FACS is a problem when using streptavidin-coated magnetic
beads [20], but the use of microfluidic sorting, such as MMS
reported here and DACS results reported for epitope mapping
[20], along with biotin additive to sorting seemingly decreases this
unwanted enrichment The selection of PA binders and not SAPE
binders was further evidenced with the PA on-cell binding affinity
curves (Fig. 7) that used PA-488 instead of the PA-SAPE labeling
for flow cytometry analysis. The results herein support the known
Figure 2. MMS Disposable Cartridge. The disposable MMS
cartridge is made from polypropylene with outer dimensions of
120 mm655 mm. The sample is mixed with buffer 1 prior to entering
the trapping region. Buffer 2 is used to wash away all of the cells not
bound to magnetic beads in the trapping region, which are collected at
the negative cell outlet. Buffer 2 is also used to elute the cells trapped
on the magnetic beads into the positive cell outlet for overnight growth
for subsequent sorting or analysis of the enrinched population.
doi:10.1371/journal.pone.0026925.g002
Figure 3. Rare-cell and Ultra-rare Cell Recovery Comparison.
Rare-cell and ultra-rare cell recovery results for the MMS (black) and
manual MACS (red) comparison. In four independent trials, both the
MMS and MACS show cell recovery down to 10
28, with the MMS having
greater between experiment cell recovery performance through all of
the populations tested, given the smaller RMSD reported as error bars
for each sample.
doi:10.1371/journal.pone.0026925.g003
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further studies with the use of biotin, SAPE, or a-biotin PE in
MMS and MACS and FACS with bacterial peptide display
libraries are warranted.
In addition to higher throughput, purity, and reproducible
recoverability, for the first time, a PA binder sequence consensus
WXCFTC was discovered and is corroborated with a PA binder
selected by the classical MACS/FACS selection. Furthermore, the
sorting protocols described here can be easily adapted to select
other affinity reagents (yeast library comparison currently
underway), by modifying the existing sorting methods in the
LabVIEW interface, including, but not limited to, changing wash
volumes, flow rates, and elution volumes.
ThecurrentresultsnotonlydemonstratethepotentialoftheMMS
platform for automated reagent discovery but could lead to a much
broader extension to a variety of applications requiring rare-cell
recovery for this or similar microfluidic technology. For example, the
ability to consistently recover and isolate a rare cell population from a
large negative control population provides a useful method for
pathogen detection in food and water using this low cost, disposable
cartridge system. The use of a disposable cartridge permits the
analysis of potentially hazardous materials with minimal user
exposure and eliminates any concerns for cross-contamination of
samples. Above all, the MMS performs with consistency and can be
coupled with display librariesto rapidlyisolate peptide affinity binders
for sensing, diagnosis, or detection of potential biohazard threats,
such as protective antigen of Bacillus anthracis.
Materials and Methods
Micromagnetic sorter (MMS) System
MMS Disposable Microfluidic Card. The Micro-Magnetic
Sorter (MMS) is an automated magnetic separation system
consisting of a disposable microfluidic cartridge (Fig. 1a) and a
companion instrument (Fig. 1b). The disposable cartridges are
made of injection-molded polypropylene (Pinnacle Polymers PP
5135C). The 200 mm deep fluidic channels are defined by two
injected parts, which are laser-welded (California Lasers, Simi
Valley, CA) and a portion is heat staked with a hydrophobic
membrane for bubble removal (Pall Co, Ann Arbor, MI) through
the bubble trap (Fig. 1a). The trapping region (Fig. 1a) was
designed to accommodate up to 1610
9 of 1 mm trapped magnetic
beads and process up to 1610
11 bacterial cells. The trapping
region has a total surface for binding of approximately 11.3 cm
2
and total volume of 226 ml (11.3 cm
260.200 cm depth). Female
luer fittings on the top of the cartridge allow for a leak-proof
interface between the cartridge and disposable syringes (Becton
Dickinson, San Jose ´, CA). The luer fittings on the cartridge are
designed to hold a reservoir array, for pneumatically driven
applications as well as the injector inputs. There are a total of four
luer ports required for two sample injectors (1 or 5 mL volume),
one running/wash buffer injector (up to 10 mL) and one elution
buffer injector (up to 3 mL volume). Strategically designed micro-
channels allow for full automation of magnetic separation on the
cartridge. To accomplish this, five pneumatically actuated pinch
Figure 4. Flow Cytometry Analysis of MMS Results per Sorting Round. Flow cytometry analysis of the fraction of target-binding clones in the
enriched population after incubation with Streptavidin-R-Phycoerythrin (SAPE) fluorescently labeled biotinylated PA protein target. The intensity of
PE fluorescence (y-axis) represents the level of binding on the cell surface; this may be due to either a high expression or a high affinity for the target.
Following one round of MMS, 0.7% (net) of the population exhibited PA binding peptides. Following two rounds of MMS, 56.5% (net) of the
population exhibited target-binding peptides. And 65.1% (net) of the population exhibited target-binding peptides after three rounds MMS selection.
doi:10.1371/journal.pone.0026925.g004
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for the redirection of flow to one of the elution ports (Fig. 1a)
during washing of unbound cells (to negative cell outlet) or elution
of magnetically bound cells (positive cell outlet) (Fig. 2). These
valve membranes require a force of ,15 lb/in
2 to seal and are
robust enough to be actuated multiple times.
MMS Instrumentation. The instrument utilizes a cRIO
controller with LabVIEW script (National Instruments, Austin,
TX) outfitted with standard digital and analog in/out modules for
control of the internal components. Flow rates within the cartridge
are controlled by four stepper motors (Fig. 1c) and controller
boards (Haydon and Anaheim Automation), which physically push
on the injectors (Fig. 1d). These motors are fitted with micro-
switches (Fig. 1c) (Panasonic ECG, Secaucus, NJ) that allow for the
automatic calculation of input volume. Valves on the cartridge are
actuated using pneumatically controlled air cylinders (SMC Corp,
Noblesville, IN) and a DC diaphragm pump (Thomas provided by
Nor Cal Controls, San Jose, CA). There are seventy custom
neodymium-iron boron magnets, which are position-controlled by
another Haydon stepper motor. The magnets are distributed
equally among top and bottom portions of a magnetic rack, which
sandwich the disposable cartridge. A single motor, in conjunction
with a spring, allows for both horizontal and vertical movement of
magnets. This facilitates horizontal movement required for
trapping and elution, and vertical movement capable of
agitating the sample within the cartridge.
Cell Preparation for MMS Sorting
A bacterial display library (Cytomx Therapeutics; San Fran-
cisco, CA: eCPX library) which contains approximately 3610
10
members was screened for clones that display PA binding peptides
The random library is first grown in 500 mL LB media containing
25 mg/mL chloramphenicol (LB-Cm
25)t oa nO D 600 nm of
approximately 0.6 (Eppendorf Biophotometer; Eppendorf, Ham-
burg, Germany) prior to induction by 0.04% (w/v) arabinose(the
Figure 5. MACS/FACS results of MACS_545 Sample. Flow
cytometry analysis of the fraction cell binding through conventional
MACS plus FACS sorting after incubation with Streptavidin-Phycoery-
thrin (SAPE) labeled biotinylated PA protein target. The intensity of PE
fluorescence (y-axis) represents either the expression of the surface
peptide or affinity of the target to the display peptide. In the top dot
plot, the cells are incubated with SAPE+biotin-PA prior to arabinose
induction (negative control). The bottom dot plot shows the fraction PA
bound after arabinose induction of the MACS_545 cells.
doi:10.1371/journal.pone.0026925.g005
Figure 6. Sequence Alignment of MMS and MACS/FACS Sorts.
Peptide sequences of clones selected by MMS system and MACS for
binding to protective antigen. Conserved residues are highlighted in
blue, similar residues in green, and identical residues in yellow. All of
the twenty-four MMS selected sequences and one of the MACS
sequences contained a six residue consensus sequence of WXCFTC.
doi:10.1371/journal.pone.0026925.g006
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library peptides is under the control of an arabinose inducible
promoter) [11]. The cells were shaken at 37uC for an additional
45 mins, after which the OD600 nm was again measured and, using
the assumption that an OD600 nm of 1.0 relates to a bacterial
concentration of 1610
9 cfu/mL, approximately 2610
11 cells were
pelleted by centrifugation at 3000 g for 20 mins.
Streptavidin-binder depletion
The bacterial pellet was re-suspended in 1.5 mL of PBSB (PBS
buffer plus 0.5% BSA) containing 1610
9 paramagnetic beads
(Invitrogen DynabeadsMyOneStreptavidin C-1; Invitrogen, Carls-
bad, CA). The cell suspension was incubated at 4uC for 45 mins
with rotation to allow depletion of streptavidin binders from the
library prior to selections. To remove these beads and any cells
bound to them, the sample was loaded onto an MMS cartridge
and separated at a sample flow rate of 50 mL/hr and buffer flow
rate of 10 mL/hr. The MMS cartridge captured the unwanted
bead bound cells and allowed collection of the depleted library
ready for enrichment. For the SA binder depletion using a
benchtop magnetic bead separator (manual MACS), the bacterial
cell pellet with 1610
9 paramagnetic beads was pelleted using a
magnet next to the tube. The magnetic separation was performed
for 5 mins to allow the bead pellet to form; the sample was washed
and aspirated with 561 mL PBS washes, and re-suspended in
1 mL PBSB for PA binder enrichment.
PA-binder enrichment
The SA-binder depleted library was centrifuged at 3000 g for
20 mins, re-suspended in 1 mL PBSB buffer containing 600 nM
biotinylated protective antigen (EZ-Link Sulfo-NHS biotinylation
kit; Thermo Scientific, Rockford, IL; List Biological Laboratories,
Inc; Campbell, CA), and incubated at 4uC for 45 mins. Cells were
centrifuged as above and re-suspended in 1 mL PBSB buffer with
1610
9 pre-washed magnetic beads. After 45 mins at 4uC with
rotation, the cell-beads suspension was loaded into an MMS
cartridge (or separated by manual MACS using the same methods
as SA binder depletion). Bacterial cells bound to PA were trapped
on cartridge, and then eluted into a 15 mL tube. A second round
of sorting was performed following the same protocol as the first;
however, the assay parameters were adjusted to account for the
smaller starting population and to increase the selection pressure
in the second round, therefore 1610
8 cells in 50 mL of 300 nM PA
and 1610
8 magnetic beads were used. Cells were incubated static
on ice for all labeling steps. Also, 1 mM biotin was added in the
washing buffer to compete with any remaining streptavidin
binders (peptides which bind to streptavidin typically have a
much lower affinity than biotin). In the third round of MMS
sorting, cells were labeled with 150 nM biotinylated PA, and then
labeled with 1610
6 magnetic beads in 50 mL of PBSB. After each
round of magnetic separation, the bead-bound enriched library
Table 1. PA and Streptavidin binding analysis of Single Clones: The percentage binding from flow cytometry of ten of the MMS
isolated clones and fourteen MACS/FACS isolated clones.
Clone
% Binding
(150 nM PA)
% Binding
(150 nM SAPE) Clone
% Binding
(150 nM PA)
% Binding
(150 nM SAPE)
MMS_140 88.0 0.3 MACS_583 22.7 1.5
MMS_127 56.5 0.3 MACS_578 10.0 1.1
MMS_142 71.2 0.1 MACS_584 3.4 0.8
MMS_105 71.6 0.7 MACS_581 13.7 0.6
MMS_133 77.1 0.3 MACS_587 53.2 1.8
MMS_109 47.4 0.5 MACS_541 33.6 0.4
MMS_128 89.8 0.2 MACS_563 7.0 1.4
MMS_111 44.1 0.2 MACS_572 5.1 7.9
MMS_188 88.4 39.5 MACS_550 1.2 2.9
MMS_141 80.6 0.4 MACS_575 14.4 8.2
MACS_576 3.9 0.6
MACS_545 62.0 16.3 MACS_574 23.6 3.1
MACS_579 31.8 2.7
Each clone was tested against Dylight 488 labeled PA at 150 nM and Streptavidin-Phycoerythrin (SAPE) at 150 nM to assess the initial affinity to PA and the cross-
reactivity to SAPE at 150 nM.
doi:10.1371/journal.pone.0026925.t001
Figure 7. Affinity Analysis of Single Clones. Flow cytometry
affinity analysis of the highest affinity clones for MMS and the best
MACS/FACS clone. The cells were analyzed for affinity using 500, 250,
50, 25, 5, 2.5, 0.5, and 0 nM of the PA-Dylight 488 sample. The
dissociation constant (KD) is shown for each sample.
doi:10.1371/journal.pone.0026925.g007
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25 media supplemented with 0.2% glucose to
inhibit expression of the eCPX gene and therefore prevent growth
bias. The cultures were then grown overnight at 37uC with
shaking.
MACS/FACS Sorting
The optimized protocol was similar to previously published
procedures [4,12]. Briefly, The SA-binder depleted library was
screened by FACS (BD FACSAria; BD Biosciences, Franklin
Lakes, NJ), and PA binding clones were selected. This was
repeated three times, alternating the secondary label between
SAPE and an anti-biotin-PE antibody, which reduces enrichment
of binders to the secondary label. After three rounds a highly
enriched PA binding population was obtained. Binding was also
assessed in the presence of BSA (Bovine Serum Albumin) and
human IgG; binding to target was not reduced in the presence of
these interferents, suggesting a specific interaction with PA.
Analysis of PA binder enrichment by flow cytometry
To quantify the library enrichment of potential PA binders, flow
cytometry analysis (BD FACSCanto II; BD Biosciences, Franklin
Lakes, NJ) was performed using biotinylated PA labeled with
alternating fluorescent secondary labels: streptavidin, R-phycoer-
ythrin conjugate (SAPE; Invitrogen, Carlsbad, CA), anti-biotin-
phycoerythrin (Miltenyi Biotec; Bergisch Gladbach, Germany),
and Neutravidin, R-phycoerythrin conjugate (NAPE; Invitrogen,
Carlsbad, CA), similar to previously published procedures [4,12].
Following each round of PA selection, the arabinose induced cell
population was incubated with 100 nM biotin-PA solution for
45 mins. The sample was centrifuged at 3000 g for 10 mins to
remove unbound biotin-PA and was resuspended in a 25 mL
solution of PBSB with secondary label concentration of 5 mg/mL
and incubated for 45 mins at 4uC. The sample was centrifuged
and resuspended in 1 mL ice-cold BD FACSFlow (BD Bioscienc-
es, Franlin Lakes, NJ) sheath immediately prior to flow cytometry.
Cells labeled with SAPE exhibit increased red fluorescence and are
easily distinguishable by flow cytometry.
Affinity analysis of PA binders by flow cytometry
PA protein was labeled with Amine Reactive Dylight-488 NHS
Ester dye molecule (Pierce Protein; Rockford, IL) according to the
manufacturer’s instructions. Briefly, a 1 mg sample of PA was
dissolved into 2 mL of 0.1 M sodium carbonate pH=8.5. The
solution was added to a 50 mg sample of Dylight-488 NHS Ester
for protein-dye conjugation. The protein-dye mixture was
incubated for 1 hr at room temperature. The non-reacted, dye
was removed by dialysis using a Slide-A-Lyzer 10 k MWCO
membrane (Pierce Protein; Rockford, IL). To determine the on-
cell binding affinity of each clone, the cells were grown and
induced similar to Sorting Procedures and Sample Preparation
mentioned above. A 25 ml PBSB solution of varying PA-Dylight
488 concentrations (500, 250, 50, 25, 5, 2.5, 0.5, 0 nM) was
incubated with 5610
6 cells for 45 mins on ice. The samples were
pelleted by centrifugation at 30006g for 5 mins and resuspend in
500 ml BD FACSFlow for binding affinity analysis.
Ultra-Rare Cell Recovery
To measure the rare and ultra-rare cell recovery of the MMS,
negative control cells not expressing surface display peptides were
doped with a known quantity of cells expressing a known PA
binding sequence (MACS_545). A 1610
23 or 0.1% PA binder
(1 mL PA binding bacteria in 1 mL on negative control bacteria at
identical OD600) sample was serially diluted using 1 mL of cells in
10 mL of negative control library to create samples ranging from
1610
24 to 1610
28 or 0.0000001% PA binding cells. The samples
were analyzed by flow cytometry during four independent trials
before and after MMS (or MACS) sorting to determine the ultra-
rare cell recovery capability of each method.
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